Ayrton Capital’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Ayrton Capital’s Portfolio CMRAW Stock Details CMRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.17K	Hold	100,000	–	–	0.01%	57
2023 Q2	$2.71K	Hold	100,000	–	–	0.02%	60
2023 Q1	$4.31K	Hold	100,000	–	–	0.02%	64
2022 Q4	$4.77K	Hold	100,000	–	–	0.01%	69
2022 Q3	$6K	Hold	100,000	–	–	0.01%	91
2022 Q2	$14K	Buy	+100,000	New	+$16.4K	0.02%	75

Other funds holding CMRAW

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Ayrton Capital's CMRAW Position: Q3 2023 in Review

Ayrton Capital held its Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) position steady in Q3 2023 at 100,000 shares worth $2.17K. The position accounts for 0.01% of the portfolio, ranked #57.

Ayrton Capital first reported a position in CMRAW in Q2 2022 and has held it in 6 quarters since. The position peaked at $14K in Q2 2022. 15 funds tracked by Wall St. Rank hold CMRAW as of Q3 2023.

Ayrton Capital held 100,000 shares of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 worth $2.17K as of Q3 2023.
Ayrton Capital left its Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 share count unchanged in Q3 2023.
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 made up 0.01% of Ayrton Capital's portfolio in Q3 2023, its #57 holding.
Ayrton Capital first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and has held it in 6 quarters since.
Ayrton Capital's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $14K in Q2 2022.
15 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q3 2023.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.